HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jegaden, O. Articles by Mikaeloff, P. H. Search for Related Content PubMed PubMed Citation Articles by Jegaden, O. Articles by Mikaeloff, P. H.

European Journal of Cardio-Thoracic Surgery, Vol 6, 256-260, Copyright © 1992 by European Association for Cardio-thoracic Surgery

ARTICLES

Long-term results of porcine bioprostheses in the tricuspid position

O Jegaden, M Perinetti, M Barthelet, C Vedrinne, F Delahaye, P Montagna and PH Mikaeloff
Department of Cardiac Surgery, Cardiovascular and Pneumologic Hospital, Lyon, France.

Between 1974 and 1990, 58 patients underwent tricuspid valve replacement with porcine bioprostheses (Hancock 42, Carpentier-Edwards 16) during multiple valve replacement (double, 21; triple, 37). Perioperative mortality was 12%; 16 patients died later, mostly from cardiac causes. Actuarial survival (1 patient lost to follow-up) was 81% +/- 11% at 5 years, and 60 +/- 17% at 10 years. Reoperation because of Hancock prosthesis deterioration was performed in 2 patients at 11 and 15 years, respectively. At last follow-up (mean 108 +/- 48 months), 82% of survivors (28/34) were functionally improved. Doppler echocardiography was performed in 29 patients in February 1991. In 21 patients, after 88 +/- 40 months of follow-up, the bioprosthesis was normal, there was no leaflet malformation, no significant tricuspid regurgitation and the mean diastolic transprosthetic gradient (DTPG) was 3.8 +/- 1.7 mmHg. In 7 patients (follow-up: 129 +/- 40 months, P less than 0.05), there was moderate dysfunction (all Hancock prostheses) with leaflet sclerosis, tricuspid regurgitation grade 2, and mean DTPG 5.7 +/- 1.8 mmHg (P less than 0.05). Only 1 patient (Hancock prosthesis implanted in 1981) had severe tricuspid prosthesis stenosis with very thickened leaflets and mean DTPG 13 mmHg. Pulmonary artery hypertension (most often fixed) was present in 11 patients, associated with a poor functional result and a significantly higher DTPG. We conclude that porcine bioprostheses in tricuspid position have an acceptable long-term durability and satisfactory performance. Prosthetic dysfunction correlates with the length of follow-up of patients and with the presence of fixed pulmonary artery hypertension.

This article has been cited by other articles:

				M. Kobayashi, T. Asou, Z.-B. Lin, Y. Takeda, K. Ohara, and H. Yoshimura Bioprosthetic Dysfunction Caused by Preserved Native Valve in Tricuspid Position Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 72 - 73. [Abstract] [Full Text] [PDF]

				C. P. Ratnatunga, M.-B. Edwards, C. J. Dore, and K. M. Taylor Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prostheses Ann. Thorac. Surg., December 1, 1998; 66(6): 1940 - 1947. [Abstract] [Full Text] [PDF]

				H. E. Scully and C. S. Armstrong Tricuspid valve replacement: Fifteen years of experience with mechanical prostheses and bioprostheses J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1035 - 1041. [Abstract] [Full Text]